---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-023698"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2026-06-02T19:35:05+00:00"
generated_at: "2026-06-02T19:36:07.202296+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# PDS Biotech regains Nasdaq minimum bid price compliance as of June 2, 2026

## Summary
- Nasdaq notified PDS Biotech on June 2, 2026 that it regained compliance with the $1.00 minimum bid price rule.
- The company had fallen below $1.00 for 30 consecutive business days, triggering a deficiency letter on Feb 25, 2026.
- Nasdaq has closed the matter; no further compliance actions required for this issue.

## SEC filing metadata
- accession: 0001140361-26-023698
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2026-06-02T19:35:05+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036126023698/0001140361-26-023698-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036126023698/ef20075449_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-023698
- JSON: https://secwatch.observer/filing/0001140361-26-023698.json
- Plain text: https://secwatch.observer/filing/0001140361-26-023698.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.